The Chinese State Food and Drug Administration said in the third drug quality report of 2008 that it had identified 13 substandard drugs while conducting a spot-check of pharmaceuticals.
The drugs checked were the two biological products Japanese Encephalitis live attenuated vaccine and measles vaccine; and four drugs Qing Kai Ling Injection, theophylline, nimodipine, and nitroglycerin tablets. SFDA said the 103 samples of the two vaccines they examined, Japanese Encephalitis live attenuated vaccine and measles vaccine, were all up to standard. However, of the 295 theophylline samples, four made by Jinzhou Jiutian Pharmaceutical Company with the series number of 20071001 and five made by Sichuan Xicheng Pharmaceutical Company with the series number of 080101 were substandard.
SFDA spot-checked 862 Nimodipine samples. Of these, four were found to be substandard and they were all said to be made by Chongqing Kerui Pharmaceutical Company with the series number of 070501.
All the 266 Qing Kai Ling Injection samples and 328 nitroglycerin tablets samples were reported to be up to standard.
